Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis

NCT00309062 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Birch Pollen Allergy

Interventions

BIOLOGICAL: Recombinant birch pollen

Sponsor

Allergopharma GmbH & Co. KG